InVivoSwiss SA

Founded in 2014 as a spin-out company from EPFL, InVivoSwiss is an innovative preclinical optical imaging company with an exclusive patent pending technology based on the combination of activatable probes tailored to key pharmaceutical targets, a novel implantable biosensor technology and a wearable optical imaging device, compatible with all preclinical animal models. The combination of these unique technologies accelerate our clients drug discovery pipelines by facilitating the non-invasive monitoring of biological pathways and targets in live animals. InVivoSwiss offer custom probe design, reporter technology, hardware and expertise for virtually any optical imaging application.